Evidence map›Paper›PMID 17123129›Full record

ArticleExtremophiles : life under extreme conditions2007

The lysogenic region of virus phiCh1: identification of a repressor-operator system and determination of its activity in halophilic Archaea.

M Iro, R Klein, B Gálos, U Baranyi, N Rössler, A Witte

Abstract read
PubMed Publisher
In one paragraph

Article in Extremophiles : life under extreme conditions, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Archaeal tyrosine recombinases.FEMS microbiology reviews · 2021
    Review
  2. The LUCA and its complex virome.Nature reviews. Microbiology · 2020
    Review
  3. Genes · 2019
    Article
  4. Mechanisms of gene flow in archaea.Nature reviews. Microbiology · 2017
    Review
  5. Article
  6. Viruses of haloarchaea.Life (Basel, Switzerland) · 2014
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M IroDepartment of Microbiology and Immunobiology, Max F. Perutz Laboratories, University of Vienna, Dr. Bohr-Gasse 9, Vienna, 1030, Austria.
R Klein
B Gálos
U Baranyi
N Rössler
A Witte
Max Perutz Labs · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

phiCh1 is a temperate virus infecting the haloalkaliphilic archaeon Natrialba magadii. As for all temperate viruses, a control of the lysogenic state versus the lytic life cycle is essential. Two open reading frames (ORFs) have been identified as putative repressor encoding genes: ORF48 and ORF49. The protein of ORF48 showed sequence similarities to putative repressor molecules. ORF49 was identified by the analysis of a mutant of phiCh1: the lysogenic strain carrying mutant phiCh1-1 showed a different lysis behavior than wild type virus phiCh1, indicating a dysfunction in the regulation of gene expression. Here, we show that the intergenic region between ORF48 and ORF49 comprises a promoter/operator sequence that is a transcriptionally active region in the model system Haloferax volcanii. Transcription from this region can be repressed by the activity of the ORF48 gene product. Gp43/gp44 has an enhancing effect on this regulatory sequence. Evidence is given for a possible binding site of Rep and gp43/gp44 within the coding region of the rep gene.

Indexed as

Operator Regions, GeneticArchaeal VirusesGene Expression Regulation, ViralHalobacterialesLysogenyMutationOpen Reading FramesPromoter Regions, GeneticRepressor ProteinsTranscription, GeneticViral ProteinsRepressor ProteinsViral Proteins

Identifiers

PMID17123129
OpenAlexW2003840987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.